润达医疗
(603108)
| 流通市值：58.89亿 | | | 总市值：58.89亿 |
| 流通股本：6.05亿 | | | 总股本：6.05亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 4,791,533,899.21 | 3,193,709,975.77 | 1,510,505,870.23 | 6,998,529,976.26 |
| 营业总成本 | 4,751,236,151.38 | 3,128,160,636.06 | 1,504,546,302 | 7,099,474,285.35 |
| 其他经营收益 | | | | |
| 营业利润 | -33,514,398.94 | 552,713.1 | -35,366,147.69 | -450,256,039.42 |
| 利润总额 | -55,186,679.27 | -10,526,371.06 | -36,031,580.17 | -460,637,227.99 |
| 净利润 | -147,595,142.21 | -61,421,266.16 | -45,973,945.25 | -518,150,880.46 |
| 每股收益 | | | | |
| 其他综合收益 | 3,890,717.06 | 3,066,687.42 | 1,343,539.1 | -10,279,338.19 |
| 综合收益总额 | -143,704,425.15 | -58,354,578.74 | -44,630,406.15 | -528,430,218.65 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 7,552,121,361.85 | 7,859,845,318.18 | 8,165,273,801.71 | 8,517,122,013.7 |
| 非流动资产: | | | | |
| 非流动资产合计 | 4,824,030,121.82 | 4,860,055,851.65 | 4,928,100,194.3 | 4,900,639,429.67 |
| 资产总计 | 12,376,151,483.67 | 12,719,901,169.83 | 13,093,373,996.01 | 13,417,761,443.37 |
| 流动负债: | | | | |
| 流动负债合计 | 7,315,459,004.02 | 7,381,860,152.6 | 7,547,349,999.74 | 7,678,722,341.76 |
| 非流动负债: | | | | |
| 非流动负债合计 | 511,469,697.68 | 648,586,100.47 | 767,387,689.05 | 857,577,146.21 |
| 负债合计 | 7,826,928,701.7 | 8,030,446,253.07 | 8,314,737,688.79 | 8,536,299,487.97 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,604,822,812.63 | 3,690,652,516.09 | 3,724,105,674.27 | 3,786,137,673.65 |
| 股东权益合计 | 4,549,222,781.97 | 4,689,454,916.76 | 4,778,636,307.22 | 4,881,461,955.4 |
| 负债和股东权益合计 | 12,376,151,483.67 | 12,719,901,169.83 | 13,093,373,996.01 | 13,417,761,443.37 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 5,693,795,907.26 | 3,684,939,351.28 | 1,824,134,638.46 | 8,556,781,165.21 |
| 经营活动现金流出小计 | 4,969,118,659.03 | 3,411,655,379.62 | 1,777,955,896.43 | 7,919,558,954.44 |
| 经营活动产生的现金流量净额 | 724,677,248.23 | 273,283,971.66 | 46,178,742.03 | 637,222,210.77 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 576,333,298.87 | 387,290,469.73 | 144,255,051.72 | 571,439,794.2 |
| 投资活动现金流出小计 | 654,447,660.85 | 433,916,930.16 | 267,660,423.19 | 810,903,901.54 |
| 投资活动产生的现金流量净额 | -78,114,361.98 | -46,626,460.43 | -123,405,371.47 | -239,464,107.34 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 6,728,933,744.48 | 4,521,440,139.19 | 2,265,189,288.5 | 7,981,928,849.83 |
| 筹资活动现金流出小计 | 7,671,676,540.62 | 5,025,426,803.23 | 2,365,158,273.31 | 8,601,333,132.28 |
| 筹资活动产生的现金流量净额 | -942,742,796.14 | -503,986,664.04 | -99,968,984.81 | -619,404,282.45 |
| 汇率变动对现金及现金等价物的影响 | -1,409,812.46 | -1,289,220.89 | -587,367.3 | -319,395.78 |
| 现金及现金等价物净增加额 | -297,589,722.35 | -278,618,373.7 | -177,782,981.55 | -221,965,574.8 |
| 期末现金及现金等价物余额 | 369,455,987.96 | 388,427,336.61 | 489,262,728.76 | 667,045,710.31 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -278,618,373.7 | - | -221,965,574.8 |